ArticleDiagnostics (Basel, Switzerland)2026
Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy.
Juan Ramón Berenguer-Marí, Luis Álvarez, Julia Sierra-Roca, Raquel Bosch-Romeu, Irene Tadeo-Cervera, Juan Pardo, Antonella Locascio, Juan Bautista Laforga, Antonio Falcó, Juan Manuel Gasent-Blesa and 1 more
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Luis ÁlvarezPASAPTA Department, Veterinary School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain.
Julia Sierra-RocaDepartment of Obstetrics and Gynecology, La Ribera Salud, 46015 Sueca, Spain.
Raquel Bosch-RomeuDepartment of Mathematics, Physics and Technological Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain.ORCID 0000-0001-9126-3241 Irene Tadeo-CerveraPASAPTA Department, Veterinary School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0003-3690-5007 Juan PardoDepartment of Mathematics, Physics and Technological Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain.ORCID 0000-0003-4184-9855 Antonella LocascioSchool of Health Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 45115 Valencia, Spain.ORCID 0000-0001-8026-1937 Juan Bautista LaforgaDepartment of Pathology, Hospital de Denia, 03700 Alicante, Spain.
Antonio FalcóDepartment of Mathematics, Physics and Technological Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain.ORCID 0000-0001-6225-0935 Juan Manuel Gasent-BlesaPASAPTA Department, Veterinary School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain.
Joan ClimentPASAPTA Department, Veterinary School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-8927-6614 Funding
Universidad Cardenal Herrera CEU INDI 24/11 and GIR24/10
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
immunohistochemistrylongitudinal TP53 changesneoadjuvant chemotherapyp53pathological complete responseprognosisTP53triple-negative breast cancer
Identifiers
PMID42882384
PMCPMC13663948
What OpenQuestion holds
Textmetadata
Read underepoch 390